RxDoctor Payments Data

Michael Shepherd, MD

Family Medicine · Chattanooga, TNNPI 1962481713

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $112, 6.7 times the $17 reported in 2023. That places this record below the midpoint for family medicine clinicians in TN, where the typical reported total is $470.

$201in general payments, 2019–2025

Across 9 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$37
  • Biogen$30
  • AbbVie$27
  • Medtronic$26
  • Exact Sciences$25
  • Bayer$23
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$201100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC2$37
Biogen1$30
AbbVie1$27
Medtronic1$26
Exact Sciences1$25
Bayer1$23
Novo Nordisk1$17
Amgen1$17

How this compares

$201 in reported general payments places this provider in the 35th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$7,784
Medicare patients
60
Services billed
120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide23$21,421
EliquisApixaban15$15,486
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen47$1,197
Albuterol Sulfate HfaAlbuterol Sulfate36$917
Pantoprazole Sodium34$450
Rosuvastatin Calcium27$433
Nifedipine ErNifedipine16$400
Gabapentin25$362
Losartan Potassium16$326
Atorvastatin Calcium30$317
Omeprazole27$266
Lisinopril34$252
Amlodipine Besylate36$207
Tamsulosin Hcl18$202
Fluticasone Propionate15$200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$17$21,42123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →